StonvexLoading…
StonvexCore line items from RMAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $74.15M | $70.23M | $291.60M | $220.46M | $147.22M |
Operating Income | Not available | $-7.82M | $47.04M | $37.73M | $19.41M |
Net Income | Not available | $-9.74M | $13.43M | $6.71M | $2.73M |
EPS (Diluted) | $0.40 | Not available | Not available | Not available | Not available |
Total Assets | Not available | $572.35M | $582.48M | $582.20M | $574.80M |
Total Liabilities | Not available | $614.00M | $611.46M | $617.05M | $618.36M |
Cash & Equivalents | Not available | $107.13M | $118.74M | $107.48M | $94.31M |
Free Cash Flow OCF − CapEx | Not available | $-4.26M | $33.50M | $23.33M | $6.91M |
Shares Outstanding | Not available | Not available | Not available | Not available | Not available |